AAEM Signs on to Joint Letter Encouraging the Passage of the Mainstreaming Addiction Treatment Act

AAEM, with assistance from the AAEM EM Pain and Procedural Sedation Interest Group, signed on to a letter today asking Congressional leaders to pass the Mainstreaming Addiction Treatment Act (MAT Act, H.R. 2482, S. 2074).

"In response to the coronavirus pandemic, the twelve undersigned organizations representing behavioral health and substance use disorder treatment providers and public health advocates write to encourage Congress to pass the Mainstreaming Addiction Treatment Act (MAT Act, H.R. 2482, S. 2074). This bipartisan, bicameral legislation would remove the federal barrier established by the DATA 2000 Act that requires health care practitioners to obtain a waiver from Drug Enforcement Administration (DEA) before prescribing buprenorphine, one of three drugs approved by the Food and Drug Administration (FDA) to treat opioid use disorder (OUD)..."

This letter was signed by:

American Academy of Emergency Medicine
American College of Emergency Physicians
American College of Medical Toxicology
American Foundation for Suicide Prevention
Community Catalyst
Drug Policy Alliance
Harm Reduction Coalition
National Association of Attorneys General
National Council for Behavioral Health
National Health Care for the Homeless Council
Shatterproof
The Pew Charitable Trusts

 

 

Share

Social Media PolicyWebsite Disclaimer